Drug Profile
Aldumastat - Galapagos
Alternative Names: G504572; GLPG-1972; S-201086Latest Information Update: 11 Feb 2022
Price :
$50
*
At a glance
- Originator Galapagos NV
- Developer Galapagos NV; IRIS; Servier
- Class Antirheumatics; Cyclopropanes; Fluorobenzenes; Imidazoles; Piperazines; Small molecules
- Mechanism of Action ADAMTS5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Osteoarthritis